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E-mail address: riosjl@uv.es (J.L. Ríos).Fermentation and roasting are the main causes of polyphenol degradation during the process for obtain-
ing cocoa products. In the present study, a process for obtaining polyphenol-rich cocoa products on an
industrial scale is described. The process avoids the fermentation and roasting steps and includes a step
for the inactivation of the enzyme Polyphenol Oxidase (PPO), which helps preserve the polyphenol con-
tent present in the raw cocoa bean. In addition, our study evaluates the antioxidant capacity and charac-
terizes the flavonoid profile of the polyphenol-rich cocoa products obtained from the natural polyphenol-
rich cocoa cake. Using different protocols, we have obtained three cocoa extracts with high polyphenol
content, namely extracts A (167 mg/g), B (374 mg/g) and C (787 mg/g). The scavenging capacity of the
extracts was measured as their ability to bleach the stable radicals DPPH and ABTS+ while their antiox-
idant effect was evaluated with the FRAP assay. The results for A, B and C in the DPPH test expressed as
Trolox equivalent (lmol)/mg dry weight of extract were 0.2, 1.4 and 3.0, respectively; in the ABTS test the
results were 1.0, 4.7 and 9.8. The antioxidant capacity expressed as ascorbic acid equivalent (lmol)/mg
dry weight of each product were 17.2, 76.1 and 207.7, respectively. The scavenging properties of cocoa
powder against the superoxide anion, H2O2, HClO, and peroxynitrite were also determined. The IC50
(lg/mL) values in the hypoxanthine/xanthine oxidase test were 77.5, 12.3 and 10.3, for A, B and C, respec-
tively, while as an HOCl scavenger the IC50 (lg/mL) values were 225.4, 73.2 and 21.5. As a peroxynitrite
anion scavenger, only extract C had a relevant effect, with IC50 (lg/mL) values of 76.1 or 110.0 in the
absence or presence of bicarbonate. None of the extracts tested showed activity in the hydrogen peroxide
test, but B and C significantly increased the deoxyribose degradation in the absence of ascorbate. Like-
wise, none of the extracts inhibited the ferrous or copper chelating activity at 100 lg/mL, but they inhib-
ited the lipid peroxidation in brain homogenates and human plasma through non-enzymatic generation
systems, with extract C giving the best IC50 (lg/mL) values: 17.4 and 8.1 against lipid peroxidation in
brain homogenates and human plasma, respectively. In conclusion, if the extractive protocol is well char-
acterized, defined and optimized, cocoa could constitute a source of polyphenols for enriching foods,
nutraceuticals and alimentary supplements.
 2010 Elsevier Ltd. All rights reserved.1. Introduction agents can prevent or heal various pathologies in which ROS areReactive oxygen species (ROS) are involved in the pathogenesis
of several human diseases, including asthma (Freeman & Crapo,
1982; Jarjour & Calhoun, 1994), rheumatoid arthritis (Odeh,
1997), atherosclerosis (Aviram, 1995; Witztum & Steinberg,
1991), inflammatory bowel disease (Keshavarzian et al., 1992),
Alzheimer’s disease (Pitchumoni & Doraiswamy, 1998), and
cancer (Azad, Rojanasakul, & Vallyathan, 2008; Federico, Morgillo,
Tuccillo, Ciardiello, & Loguercio, 2007). Fortunately, antioxidantll rights reserved.
+34 963544498.implicated (Huber, Stuchbury, Bürkle, Burnell, & Münch, 2006;
Sheweita, Tilmisany, & Al-Sawaf, 2005; Victor, Rocha, Esplugues,
& De la Fuente, 2005; Wang, Wen, Huang, Chen, & Ku, 2006; Yasui
& Baba, 2006). Moreover, there is growing evidence that consump-
tion of certain foods, dietary supplements, or traditional beverages
can lead to reductions in some of the parameters of oxidative dam-
age in biological systems (Aruoma, Bahorun, & Jen, 2003; Jie et al.,
2006; Juan, Wenzel, Ruiz-Gutiérrez, Daniel, & Planas, 2006; Kaplan
et al., 2007; Surh, 1999).
Cocoa-derived foods such as cocoa powders, chocolate, and
other cocoa-related products are polyphenol-rich foods derived
from the fermented, roasted, and industrially processed seeds of
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over the world, are studied for the most part because of the antiox-
idant and antiradical properties in vitro of some polyphenolic con-
stituents, principally procyanidins and flavan-3-ols (Wollgast &
Anklam, 2000). Phenolics of cocoa, as well as those of other plant
species, have been reported in many studies as being bio-active
compounds especially noted for their antioxidant, antiradical,
and anticarcinogenic properties (Ren, Qiao, Wang, Zhu, & Zhang,
2003; Sanbongi et al. 1998; Wollgast & Anklam, 2000).
The antioxidant properties of cocoa have been studied exten-
sively in recent years. Many approaches have been employed,
including chemical characterizations of the antioxidant species in-
volved with the aid of HPLC and HPLC-MS (Adamson et al., 1999),
in vitro chemical studies to determine the cocoa’s ability to scav-
enge stable radicals such as DPPH or ABTS+ (Hatano et al., 2002),
and in vitro biological studies and nutrigenomic-based studies to
examine the bioavailability of the major compounds of cocoa and
their in vivo interaction with cellular or molecular species (Motoh-
ashi et al., 1999).
Flavonoid-rich cocoa products and chocolate have been found
to possess relevant biological activity (Fisher, Hughes, Gerhard-
Herman, & Hollenberg, 2003; Heiss et al., 2005; Rein, Paglieroni
et al., 2000; Rein, Lotito et al., 2000). Indeed, the consumption of
flavanol-rich cocoa has been reported to improve endothelial func-
tion (Wang-Polagruto et al., 2006) and reduce pro-inflammatory
mediators (Sies, Schewe, Heiss, & Kelm, 2005), effects that have
been directly linked to the presence of procyanidin-derived metab-
olites in plasma.
The health benefits of cocoa polyphenols as reported in recent
studies have increased the interest in obtaining products fromcocoa
beansnot onlywithhighpolyphenol, but alsowithahighflavan-3-ol
content. The main flavan-3-ol compounds present in cocoa are the
monomers catechin and epicatechin, and the dimer procyanidin
B2 (Lamuela-Raventós, Romero-Pérez, Andrés-Lacueva, & Tornero,
2005). The content of these compounds is important, since a great
number of studies have reported that the bioavailability of cocoa
polyphenol is strongly related to molecular size, with smaller poly-
phenols generally being more beneficial. Compounds of lowmolec-
ular weight are found in higher concentration in the blood and have
a better chance of reaching the target organ in the body (Cooper,
Donovan,Waterhouse, &Williamson, 2009). Therefore, it seems that
the higher the amounts of monomeric and dimeric flavanols in the
cocoa product, the more health benefits the products have.
The polyphenol content in cocoa-derived products is lower
than that found in the raw material used in their production.
The major flavan-3-ol enantiomer identified in unfermented,
dried, unroasted cocoa beans is the ()-epicatechin compound.
Concentrations of ()-epicatechin content ranging from 36.4 to
43.2 mg were reported in freeze-dried beans from freshly har-
vested cocoa beans unaffected by any post-harvest treatment
(Kim & Keeney, 1984). However, during the processing of cocoa,
significant degradations of ()-epicatechin and (+)-catechin
compounds take place. The main factors contributing to these
degradations are fermentation and the high roasting tempera-
tures. In the aerobic fermentation of cocoa, ()-epicatechin,
(+)-catechin and anthocyanidin molecules are oxidized and poly-
merized in the presence of the polyphenol oxydase (PPO) enzyme.
These high molecular weight polymers (tannins) have less bio-
availability than their precursors. In recent years, research efforts
have focused on ways to mitigate or suspend the PPO enzyme
activity in cocoa in order to avoid polyphenol oxidation reactions
and polymerization. Tomás-Barberán et al. (2007) have evaluated
the best conditions for inactivating the PPO enzyme in fresh cocoa
beans by applying heat treatments with water. The optimal condi-
tions under which the lowest enzymatic browning of fresh beans
occurred were at 95 C for 5 min. In the same study, a flavonoid-enriched cocoa powder was prepared and the flavonoid profile
was characterized with the aid of HPLC-DAD-MS/MS on a labora-
tory scale (Tomás-Barberán et al., 2007). Flavanol recoveries of
79% of ()-epicatechin, 62% of (+)-catechin and 80% of procyani-
din B2 have been reported after the inactivation of the PPO
enzyme with water vapor at 95 C for 5 min in raw cocoa beans
(Cienfuegos-Jovellanos et al., 2007). In another recently published
study, no PPO activity was photometrically determined in
steamed, non-fermented beans treated at 98 C for 30 min
(Bradbury & Kschonek, 2008). Kattenberg and Willemsen (2003)
described the use of microwave heating to prevent PPO activity
in unfermented beans. Thus, the flavanol content present in a final
cocoa product depends largely on the cocoa beans’ post-harvest
handling. Since there are no acceptable processing techniques in
the conventional cocoa industry to date which avoid polyphenol
degradation as a consequence of the high temperatures used,
the optimization of such processes is of great interest. One
potential application of the resulting flavonoid-rich products
would be their application as functional ingredients in the food
industry. The high polyphenol content of the cocoa products thus
produced would endow them with the polyphenol dosage
necessary for the desired health effects without a substantial
modification of their organoleptic characteristics. As an example,
a human study has demonstrated that 30 mg/day of flavan-3-ols
(up to 5-mers) reduces blood pressure in humans (Taubert,
Roesen, Lehmann, Jung, & Schömig, 2007). If that is indeed the
case, then as little as 386 mg/day of a cocoa product rich in poly-
phenols would be sufficient to provide the amount of flavan-3-ols
(up to 2-mers) needed to lower blood pressure (Cienfuegos-
Jovellanos et al., 2009).
The present work aims to study both the antioxidant capacity
and the flavan-3-ol content of polyphenol-rich cocoa products ob-
tained through processing techniques which are not applied in the
conventional cocoa industry.2. Material and methods
2.1. Reagents, solvents, standards
Standards of (+)-catechin and (–)-epicatechin (Sigma–Aldrich,
St. Louis, MO) and procyanidin B1 and procyanidin B2 (Extrasyn-
these, Genay, France) were used for quantitative determinations.
All chemicals and biochemicals were purchased from Sigma–Al-
drich while HPLC-grade solvents were purchased from either
Scharlab (Barcelona, Spain) or Merck (Darmstadt, Germany).2.2. Preparation of polyphenol-rich cocoa products
Fresh cocoa pods of the Amazonic-Trinitary variety (CCN51
clone) from the Quevedo region in Ecuador were purchased for
the preparation of the cocoa products. The fresh pulp was removed
manually from the pods in situ. Batches of 136 kg of depulped
beans were thermally treated with water vapor at an internal bean
temperature of 95 C for 5 min by immersing the beans in 2500 L of
water to inactivate the enzyme PPO. The beans were then dried at a
controlled temperature of 45 C until a moisture content of 7% was
reached. The dried beans were cleaned and deshelled with the aid
of aspiration to obtain the nibs, which were then partially defatted
through physical pressing at a temperature of 55 C. Upon comple-
tion of this process, a natural polyphenol-rich cocoa cake with a
butter content of 12% was obtained.
The polyphenol-rich cocoa cake was then used as a rawmaterial
to obtain a cocoa powder (sample A) and two polyphenol-rich co-
coa extracts (samples B and C). For the cocoa powder production,
the cake was thermally treated in an autoclave with a saturated
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2 kg batch of a cocoa cake (control) was loaded into a chamber
prior to the heat treatment in order to assess total polyphenol
and flavanol losses. After the heat treatment, the cake was milled
and sieved to obtain a cocoa powder with a particle size of less
than 75 lm (sample A).
In a small trial, the defatted cocoa cake obtained in the indus-
trial process was extracted by means of a solid–liquid extraction
process with a hydro-alcoholic mixture consisting of ethanol 70%.
The cocoa cake was extracted at 70 C for 2 h under mechanical
stirring, the solid was filtered, and the liquid fraction was recov-
ered. This fraction was then distilled under reduced pressure to re-
move the solvent, affording an aqueous extract. After drying the
liquid extract, a polyphenol-rich cocoa extract was obtained (sam-
ple B).
The remaining liquid aqueous extract was then subjected to an
additional purification step consisting of a liquid–liquid extraction
with ethyl acetate at a temperature of 50 C. The aqueous and or-
ganic fractions were separated by means of decantation and the or-
ganic phase was recovered. After distillation to remove the organic
solvent, the product was dried to obtain a purified cocoa extract
(sample C).
Sample A was thus a natural polyphenol-rich cocoa powder
while samples B and C were polyphenol-rich cocoa extracts ob-
tained from the natural-rich cocoa cake, with sample C resulting
from a purification of sample B. This procedure was expanded to
an industrial scale to obtain a range of cocoa products (Pasamar,
Ibarra, Cienfuegos-Jovellanos, & Laghi, 2006).2.3. Microbial analysis of the polyphenol-rich cocoa powder
A gram of milled cocoa was added to 100 mL of peptone solu-
tion (Scharlab, Barcelona, Spain) under sterile conditions. Serial
dilutions were cultured in Petri dishes containing the specific med-
ia for each type of microorganism. Plate Count Agar (PCA, Scharlab)
was used to facilitate the total count of mesophilic aerobic micro-
organisms. The plates were incubated at 30 C for 24 h. In the case
of total coliform, the culture was grown on ENDO agar (Scharlab)
for 72 h at 37.3 C while salmonella was grown on Rambach agar
(Merck, Darmstadt, Germany) for 24 h at 37 C. The enterobacte-
riae analysis was performed on Violet Red Bile Dextrose Agar
(VRBD, Scharlab) at 37.3 C for 24 h. The mold and yeast analysis
was carried out on Rose Bengal Chloramphenicol Agar (RBC, Schar-
lab) at 25 C for a minimum of 5 days. The results are reported as
colony forming units (cfu) per gram and are the average of at least
four measurements.2.4. Determination of the total polyphenol content in cocoa products
Polyphenol-rich cocoa powder (sample A), cocoa cakes, and the
standard cocoa powder (1 g) were extracted under reflux with
100 mL of acetone:water (70:30; v:v) at 60 C for 2 h. The acetone
was then removed under vacuum at 45 C (Tomás-Barberán et al.,
2007).
Polyphenol-rich cocoa extract (sample B) was prepared by dis-
solving 100 mg of sample in water (100 mL) with the aid of an
ultrasonic bath to ensure total dissolution of the sample.
A different polyphenol-rich cocoa extract (sample C) was pre-
pared by dissolving 100 mg of sample in 4 mL of acetonitrile with
the aid of an ultrasonic bath to ensure total dissolution of the
sample, which was then diluted with distilled water to 100 mL.
The total polyphenol content was determined with the aid of the
Folin–Ciocalteu spectrophotometric method (Singleton & Rossi,
1965). The results were expressed as catechin equivalents on a
wet weight basis.2.5. HPLC-DAD analysis of flavanols in cocoa samples
The flavanol compounds, monomeric units (catechin and epi-
catechin), and dimeric procyanidins (procyanidins B1 and B2) were
identified and quantified with the aid of reverse-phase HPLC-DAD.
Sample A, cocoa cakes (the control and the treated cake) and the
standard cocoa powder, were extracted as previously described
(Andrés-Lacueva, Lamuela-Raventós, & Jáuregui, 2000). The poly-
phenol-rich cocoa extracts (samples B and C) were prepared by dis-
solving 100 mg of each sample in water (100 mL) in an ultrasonic
bath. An additional dilution of 250 lL in 1000 lL of distilled water
was carried out before the injection. All the samples were passed
through a 0.45 lm PTFE filter (Teknokroma, Barcelona, Spain) be-
fore the injection.
Chromatography was performed on an HPLC System Agilent
1100 Series (Agilent Technologies, Waldbronn, Germany) con-
trolled by ChemStation software (Agilent, v.09.03) and equipped
with a manual injector (rheodyne 7725), G1379A degasser,
G1311A quaternary pump, G1316A column heater, and G1315B
diode array detector. Chromatographic separations were per-
formed in reverse phase on a C18 Zorbax Eclipse XDB column mea-
suring 150 mm  2.1 mm i.d. with a particle size of 5 lm (Agilent
Technologies) at a column temperature of 35 C. The chromato-
graphic separation itself was a modified version of the method de-
scribed by Tomás-Barberán et al. (2007). Flavanol identification
and quantification was carried out using external standards:(+)-
catechin, ()-epicatechin, procyanidin B1, and procyanidin B2.
The results are reported on a wet basis.
2.6. Total antioxidant activity
2.6.1. 2,2-diphenyl-1-pycryl hydrazyl (DPPH) scavenging activity
Reduction of the stable free radical DPPH was determined with
the aid of a modified version of the method described by Cavin,
Hostettmann, Dyatmyko, and Potterat (1998). The extracts
(10 lL) were added to 990 lL of DPPH in methanol (20 mg/L).
The resulting mixtures were then shaken and left for 30 min at
room temperature in the dark, after which the absorbance of the
remaining DPPH was measured at 517 nm against a blank to elim-
inate the color from the extracts. The results are expressed in lmol
trolox/mg of dry weight of the extract.
2.6.2. 2,2’-azino-bis(3-ethylbenzthiazoline-6-sulphonic acid (ABTS+)
scavenging activity
Reduction of the stable ABTS radical cation was determined
with the aid of a modified version of the method described by
Pannala, Chan, O’Brien, and Rice-Evans (2001). Briefly, (ABTS+)
was produced by reacting 7 mM of ABTS stock solution with
2.45 mM of potassium persulphate and then allowing the mixture
to stand in the dark at room temperature for 12–16 h before use.
The ABTS+ solution (2 days stable) was then diluted with 5 mM
phosphate-buffered saline (pH 7.4) to an absorbance of
0.70 ± 0.02 at 730 nm. The extracts (final concentration: 1–
100 lg/mL, 10 lL) were added to 990 lL of ABTS+ solution and
the resulting mixtures were shaken and left for 30 min at room
temperature in the dark. The absorbance of the remaining ABTS+
was then measured at 730 nm against a blank to eliminate the col-
or of the extracts. Results are expressed as lmol trolox/mg of dry
weight of the extract.
2.6.3. Ferric reducing-antioxidant power (FRAP)
The FRAP assay was carried out to determine the reducing abil-
ity of the cocoa extracts with a method adapted from Benzie and
Strain (1996). First, FRAP reagent was freshly prepared by mixing
10 mM of 2,4,6-tripyridyl triazine (TPTZ) with 20 mM of ferric
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(100 lL) were then mixed with 900 lL of FRAP reagent and, after a
30 min incubation at room temperature, the absorbance was read
at 593 nm against a blank of distilled water. Results were ex-
pressed as lmol ascorbic acid/mg of dry weight of the extract.
2.7. Metal chelating properties
The copper chelating properties of the cocoa extracts were as-
sessed as outlined elsewhere (Dillon, Burmi, Lowe, Billington, &
Rahman, 2003). In principle, the method used was based on the
reviviscence of xanthine oxidase when pre-inhibited by CuSO4 at
50 lM. The activity of the liberated xanthine oxidase was then as-
sessed by monitoring the formation of uric acid. Thus, if the ex-
tracts were able to chelate Cu2+, the activity of the pre-inhibited
xanthine oxidase should be restored. We also examined the ferrous
ion chelating ability of the extracts using the method developed by
Lopes, Schulman, and Hermes-Lima (1994). Briefly, a reaction mix-
ture containing extract, FeCl2 (0.1 mL, 2 mM), and ferroizine
(0.4 mL, 5 mM) was shaken and incubated for 10 min at room tem-
perature. The absorbance of the mixture was measured at 562 nm
against a blank. EDTA was used as a reference.
2.8. Reactive oxygen species
2.8.1. Superoxide radical scavenging activity
Superoxide radical was generated through enzymatic oxidation
of hypoxanthine with xanthine oxidase grade I (0.06 U) and was
detected by the reduction of nitroblue tetrazolium (NBT), moni-
tored spectrophotometrically at 560 nm. Details of this assay have
been described elsewhere (Schinella, Troiani, Dávila, de Bus-
chiazzo, & Tournier, 2000). The influence of the extracts on the en-
zyme activity was evaluated by measuring the uric acid formation
from xanthine. After incubation (15 min), the absorbance was
measured at 295 nm. Allopurinol was used as a reference.
Superoxide radical generation by polymorphonuclear (PMN)
cells. Human PMNs were isolated from heparinized venous blood
through sequential dextran sedimentation, differential density
sedimentation in Hypaque-Ficoll gradients, and hypotonic lysis of
erythrocytes. After centrifugation, the PMN leukocyte-rich pellets
were resuspended in Hanks’ balanced salt solution. The cytotoxic-
ity of the extracts had previously been measured with the aid of a
modified 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium
bromide (MTT) colorimetric assay (Mosmann, 1983). For the super-
oxide generation assay, the protocol described by Montesinos,
Úbeda, Terencio, Payá, and Alcaraz (1995) was used. Superoxide re-
lease was induced by addition of 12-O-tetradecanoylphorbol 13-
acetate (TPA; 1 lM). After incubation (10 min) at 37 C, the precip-
itate was dissolved in dimethyl sulfoxide (DMSO)–HCl (95:5, v/v)
and measured with a LabsystemMultiscan MCC/340 (Helsinki, Fin-
land) set at 560 nm.
2.8.2. Hydroxyl radical-scavenging assay
The hydroxyl radical-scavenging assay was carried out accord-
ing to the method described by Halliwell, Gutteridge, and Aruoma
(1987). First, hydroxyl radical was generated by incubating a reac-
tion mixture containing 20 lM FeCl3, 1.4 mM H2O2, 2.8 mM deoxy-
ribose, 2 mM EDTA, and 100 lM ascorbate in 1 mL of 10 mM
KH2PO4 – KOH buffer (pH 7.4) for 60 min at 37 C. Deoxyribose
degradation by the hydroxyl radical was then determined with
the aid of the thiobarbituric acid (TBA) method. The addition of
2.8% trichloroacetic acid (TCA) caused the color to develop, after
which 1% TBA was measured spectrophotometrically at 535 nm.
This assay was performed in triplicate with DMSO (20 mM) as a
reference.2.8.3. Scavenging of H2O2
The ability of the extract to scavenge H2O2 was determined with
the aid of the method developed by Ruch, Chen, and Klaunig
(1989). One milliliter of extract solution prepared in phosphate-
buffered saline (PBS) was incubated with 0.6 mL of 4 mM H2O2
solution (prepared in PBS) for 10 min. The absorbance of the solu-
tion was measured at 230 nm against a blank solution containing
the extract without H2O2. The concentration of H2O2 was deter-
mined spectrophotometrically from absorption at 230 nm with
the molar absorptivity set up 81 M1 cm1.
2.8.4. Potential to scavenge preformed hypochlorous acid (HOCl assay)
HOCl was prepared by adjusting the pH of a 1% (v/v) solution of
NaOCl to 6.2 with diluted H2SO4. The working concentration of the
stock solution was determined spectrophotometrically by measur-
ing its absorbance at 235 nm and applying a molar extinction coef-
ficient of 100 M1 cm1 (Weiss, Klein, Slivka, & Wei, 1982). The
reaction mixture contained taurine (10 mM), HOCl (1 mM), cocoa
powder (various concentrations), and PBS (pH 7.4) at a final vol-
ume of 1 mL. The solution was mixed thoroughly and incubated
at room temperature for 10 min after which 10 mL of KI were
added. The solution turned yellow in color and the absorbance
was measured at 350 nm.
2.8.5. Scavenging of peroxynitrite radical
2.8.5.1. Peroxynitrite synthesis. Peroxynitrite was synthesized in a
quenched flow reactor in accordance with the method described
by Koppenol, Kissner, and Beckman (1996). Acidified H2O2 (0.6 M
in 0.7 M HCl, 20 mL) was mixed with NaNO2 (0.6 M, 20 mL) to form
peroxynitrous acid (ONOOH), which was then stabilized with
NaOH (1.5 M, 40 mL) to give sodium peroxynitrite. The excess of
H2O2 was removed by mixing the solution with MnO2. The solution
was filtered and frozen at 20 C for less than 2 weeks. The con-
centration of ONOO was determined upon measuring the absor-
bance at 302 nm (e = 1670 M1 cm1).
2.8.5.2. Pyrogallol bleaching assay for peroxynitrite scavenging. The
pyrogallol red bleaching assay was carried out as reported by Bal-
avoine and Geletii (1999). Briefly, the assay was performed at 25 C
in phosphate buffer (100 mM, pH 7.0) containing 50 lM pyrogallol
red and increasing concentrations of extracts, with or without
25 mM of NaHCO3. The reaction commenced with the addition of
25 lM of ONOO and was mixed immediately. After 5 min, the de-
crease in the absorbance at 542 nm was recorded.
2.9. Inhibition of lipid peroxidation
2.9.1. Assays with brain homogenates
For the in vitro studies, the brains of normal rats were dissected
and homogenized with a Polytron (speed setting 7–8) in ice-cold
Tris–HCl buffer (20 mM, pH 7.4) to produce a 1/10 homogenate.
The homogenate was centrifuged at 10,000g for 30 min. One milli-
liter aliquots of the supernatant were then incubated with the test
samples in the presence of 10 lM FeSO4 and 0.1 mM ascorbic acid
at 37 C for 1 h. The reaction was halted upon adding 1.0 mL TCA
(28%, w/v) and 1.5 mL TBA (1%, w/v) in succession, after which
the solution was heated to 100 C for 15 min. After centrifugation
to remove precipitated protein, the characteristic color of the mal-
ondialdehyde (MDA)–TBA complex was detected at 532 nm (Liu &
Ng, 2000; Ng, Liu, & Wang, 2000).
2.9.2. Plasma oxidation
Hundred microliter of heparin plasma (200 lg ± 20 lg total
cholesterol) was diluted with 350 lL of PBS and the oxidation
was begun by adding 50 lL of CuSO4 at 10 mM. After 150 min of
incubation at 37 C, EDTA was added to stop the reaction. TBA reac-
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(Schinella et al., 2007).3. Results
3.1. Obtaining polyphenol-rich cocoa products
The process for obtaining polyphenol-rich cocoa products on an
industrial scale is summarized in Fig. 1.
3.2. Microbiological analysis of polyphenol-enriched cocoa powder
An astringent and purple cocoa powder with high procyanidin
content was obtained as previously reported, albeit on a labora-
tory, not an industrial, scale (Tomás-Barberán et al., 2007). ThisPolyphenol-Enriched 
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Fig. 1. Flow-chart of the process for obtaining polyphenol-rich cocoa products at
industrial scale.powder meets the requirements of the standard legislation as to
its content of microbial elements: total microorganisms <5000,
molds and yeast <100, enterobacteriae <10, and total absence of
Escherichia coli and Salmonella sp.3.3. Determination of total polyphenols of polyphenol-rich cocoa
products
The total polyphenol content and the flavanol profile (catechin,
epicatechin, and procyanidins B1 and B2) analyzed in the final
products (samples A–C and standard cocoa powder), and in the
intermediate products (control and steamed cake) are summarized
in Tables 1 and 2, respectively.3.4. Chromatographic profile of samples A–C
The final products (samples A–C) were analyzed with the aid of
HPLC. The major phenolic compounds (catechin, epicatechin, and
procyanidins B1 and B2) were identified as was the presence of
methylxanthines (Fig. 2A–C). Other relevant dimers such as procy-
anidin B5 present in the cocoa products were not detected. This
was also the case with trimers and tetramers.3.5. Antioxidant activity
The antioxidant capacity of plant extracts depends largely on
their composition and the conditions of the test system used. As
both of these are influenced by many factors, the antioxidant ef-
fects cannot be fully characterized with one single method. It is
thus necessary to perform more than one type of antioxidant
capacity measurement to take into account the various mecha-
nisms that contribute to the antioxidant action. We therefore em-
ployed several different methods to assess the antioxidant activity
of the samples.Table 1
Total polyphenols and flavanol profile of the standard cocoa powder, polyphenol-rich
cocoa powder (sample A) and cocoa extracts (samples B and C).
Sample Standard cocoa
powder (mg/g)
A (mg/g) B (mg/g) C (mg/g)
Total polyphenols (catechin)a 50 167 374 787
(+)-Catechinb 1.20 4.87 25.06 117.45
()-Epicatechinb 0.67 19.43 62.19 300.73
Procyanidin B1b 0.11 1.18 2.72 7.65
Procyanidin B2b 0.17 10.79 21.24 63.76
Total sum 2.15 36.27 111.21 489.59
a Results are expressed on wet basis and as catechin equivalents.
b Data obtained using reverse-phase HPLC. Data are average of duplicate test.
Table 2
Total polyphenols and flavanol profile of the intermediate products (control and
steamed cake).
Sample Control (cake before
treatment) (mg/g)
Steamed cake (after
treatment 121 C/1 min)
(mg/g)
Total polyphenols (catechin)a 183.4 181.7
(+)-Catechinb 4.97 4.00
()-Epicatechinb 20.96 20.47
Procyanidin B1b 1.12 0.51
Procyanidin B2b 12.46 12.88
Total sum 39.51 37.86
a Results are expressed on wet basis and as catechin equivalents.
b Data obtained using reverse-phase HPLC-DAD. Data are average of duplicate
test.
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Fig. 2. Reverse-phase HPLC-DAD chromatogram of flavanols from polyphenol-rich cocoa powder (samples A–C).
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extracts (10 mg/mL) to determine antioxidant activity. The scav-
enging capacity of the extracts was measured as the ability to
bleach the stable radicals DPPH and ABTS+; the results are com-
piled in Table 3. The FRAP assay, in contrast, measures the antiox-
idant effect of any substance in the reaction medium as its
reducing ability, with the values for activity expressed as ascorbic
acid equivalents in the extract (Table 3).
The scavenging properties of cocoa powder against the superox-
ide anion, H2O2, HClO, and peroxynitrite were then determined;the IC50 values are listed in Table 4. At a final concentration of
100 lg/mL, none of the extracts were able to scavenge the hydro-
xyl radical produced in the Fe3+–EDTA + H2O2 system in the pres-
ence or absence of ascorbate. Moreover, we observed a
significant increase in deoxyribose degradation caused by extracts
B and C in the absence of ascorbate (Fig. 3).
Likewise at 100 lg/mL, the polyphenol-rich cocoa extracts
exhibited no ferrous or copper chelating activity (data not shown).
We also evaluated the ability of the cocoa powder to bring about
lipid peroxidation in brain homogenates and human plasma using
Table 3
Total antioxidant activity of cocoa powder.
Sample DPPHa ABTS+a FRAPb
A 0.2 1.0 17.2
B 1.4 4.7 76.1
C 3.0 9.8 207.7
a Results are expressed as Trolox equivalent (lmol)/mg dry weight of extract.
b Results are expressed as ascorbic acid equivalent (lmol)/mg dry weight of
extract.
Table 4
Reactive oxygen species scavenging properties of cocoa powder.
Sample O2
a H2O2a HOCla ONOOa
b c d e
A 77.5 >400 >100 225.4 >400 >400
B 12.3 372.4 >100 73.2 144.7 255.7
C 10.3 315.9 >100 21.5 76.1 110.0
a Results are expressed as IC50 values (lg/mL).
b Hypoxanthine/xanthine oxidase/NBT.
c PMN/TPA/NBT.
d Without NaHCO3.
e With NaHCO3.
Table 5
Inhibition of lipid peroxidation by cocoa powder.
Sample Fe2+/ascorbate/brain homogenatea Cu2+/plasmaa
A >100 57.3
B 35.6 15.1
C 17.4 8.1
a Results are expressed as IC50 values (lg/mL).
1620 G. Schinella et al. / Food Research International 43 (2010) 1614–1623non-enzymatic generation systems. We found that the extracts
inhibited lipid peroxidation in both the homogenates and the plas-
ma. The results are summarized in Table 5.
4. Discussion
Oxygen radicals and lipid peroxides are implicated in various
physiological and pathological disorders, including those affecting
the neurological, ocular, endocrine, vascular, hemolytic, renal, he-
patic, autoimmune, pulmonary and gastrointestinal systems, as
well as in neoplasia, aging, inflammation, apoptosis, obesity, and0.0
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Fig. 3. Effects of cocoa samples A–C at a final concentration of 100 lg/mL on
hydroxyl radical produced in the Fe3+ – EDTA – H2O2 system in the presence or
absence of ascorbate. DMSO was used as a positive control.other phenomena (Armstrong, 1998). The implication of redox
mechanisms in these human diseases and aging has led to the sug-
gestion that antioxidants, in particular, plant diet-derived antioxi-
dants, might have health benefits as prophylactic agents (Aruoma,
2003). However, even after many clinical trials, the health benefits
of antioxidant compounds for humans have not been demon-
strated. There are various elements involved in this ‘‘antioxidant
paradox,” which has recently been analyzed by Halliwell. For
example, the use of high doses of antioxidants may actually be det-
rimental, with lower doses being more beneficial, as is the case
with tocopherols and carotenoids (Halliwell, 2009). Moreover,
the potential value of antioxidants is often low due to their low
levels in cells and tissue, thus limiting their possible use as thera-
peutic drugs. For example, in the therapeutic strategies to prevent
progressive neuronal loss based on antioxidant activity, the antiox-
idant must be able to cross the blood brain barrier and be present
at the respective brain region for neuroprotection (Aruoma, 2003).
That being said, food, nutraceuticals, and complementary medi-
cines facilitate the administration or ingestion of high quantities
of antioxidant compounds, which can produce high or moderate
levels of antioxidant agents in the blood and tissue. This protects
the natural antioxidants from destruction and consequently re-
duces cell and tissue damage (Heinrich & Prieto, 2008).
To date, numerous studies on the antioxidant activity of plant
extracts have been published. Of these, Lee, Kim, Lee, and Lee
(2003) compared the antioxidant effects of cocoa water extract
against water extract obtained from red wine and green and black
tea. These authors observed high activity for the cocoa extract in
both ABTS and DPPH tests, most likely due to a high content in
phenolics. Previously, Waterhouse, Shirley, and Donovan (1996)
had demonstrated that the extractive method used for preparing
various extracts affects the total phenol and flavonoid content,
which, in turn, has an effect on a given extract’s antioxidant prop-
erties. Moreover, it is likely that different experimental protocols
may also modify the antioxidant activity (Schlesier, Harwat, Bohm,
& Bitsch, 2002). In our experiments, there was a clear correlation
between the enriched samples and their antioxidant activities.
Thus, sample C has the best IC50 value as both a free radical scav-
enger (DPPH, ABTS, superoxide, hypochloride, and peroxinitrite)
and a lipid peroxidation inhibitor. These effects increased in direct
proportion to the content of polyphenols in the extract. Samples B
and C presented a higher FRAP and pro-oxidant effect in the Fe3+–
EDTA–H2O2 system, which can be directly attributed to the recog-
nized efficacy of phenolic compounds in the redox recycling of iron
(Burkitt & Gilbert, 1990). The cocoa extracts were also active in the
inhibition of superoxide production by PMNL. These results reflect
those obtained for the assay for superoxide generation in cell-free
systems. Taken together, these findings indicate that the cocoa ex-
tracts act by exerting activity on some of the biological functions of
PMNL that are implicated in the initiation and maintenance of
inflammation (Góngora et al., 2002). In addition, our extracts
showed scavenging activity against peroxynitrite in both the pres-
ence and absence of a physiological concentration of bicarbonate. It
is well-known that the peroxynitrite anion can attack a wide range
of biological molecules. The chemistry of ONOO/ONOOH is further
complicated by the formation of an adduct between ONOO and
G. Schinella et al. / Food Research International 43 (2010) 1614–1623 1621CO2 (ONOOCO

2 ), the decomposition of which results in the forma-
tion of a carbonate radical anion (CO3) and NO2 or a nitronium/
carbonate ion pair. Under physiological conditions, the levels of
bicarbonate (HCO3 ) are high and significant yields of ONOOCO

2
can be produced; however, in inflamed tissues where the pH value
is lower, different reactions independent of the presence of CO2
may occur (Kennetta & Davies, 2007).
Oxidation of unsaturated fatty acids in biological membranes
leads to the formation and propagation of lipid radicals, oxygen up-
take, rearrangement of the double bonds in unsaturated lipids, and
the eventual destruction of membrane lipids resulting in break-
down products such as malondialdehyde. Antioxidative materials
acting in living systems are classified as either preventive antioxi-
dants or chain-breaking ones. In the present study, polyphenol-rich
cocoa extracts inhibited the non-enzymatic lipid peroxidation in
rat brain homogenates, but they had no effect on the hydroxyl rad-
ical, nor did they exhibit ferrous chelating activity. Metal chelating
capacity reduces the concentration of the catalyzing transition me-
tal in lipid peroxidation. It has previously been reported that the
chelation efficiency of some compounds with a phenyl group on
Fe2+ is dependent on the number of hydroxyl groups on the ben-
zene ring, and that hydroxyl substitution in the ortho position re-
sults in a higher chelating effect (Yen, Duh, & Chuang, 2000).
However, the polyphenol-rich cocoa extracts showed neither fer-
rous nor copper chelating activity. They must therefore act as
chain-breaking antioxidants. These properties could be of great
interest in cardiovascular disease prevention therapies because
oxidative modification of LDL appears to be crucial for atherogen-
esis (Sies et al., 2005). The same authors demonstrated that cocoa
polyphenols decreased the plasma concentration of pro-inflamma-
tory cysteinyl leukotrienes through inhibition of 5-lipoxygenase,
thus suppressing lipid peroxidation in LDL. Moreover, they demon-
strated that cocoa phenols promote the bioactivity of nitric oxide
in vivo, which is critical for protecting the cardiovascular system.
In a double-blind, randomized trial with 22 heart transplant
recipients, Flammer et al. (2007) studied the effect of the ingestion
of dark chocolate (70% cocoa) on coronary vascular and platelet
function and demonstrated that phenolic-rich dark chocolate in-
duces coronary vasodilatation, improves coronary vascular func-
tion by increasing the bioavailability of nitric oxide, and
decreases platelet adhesion. These effects were parallel to a reduc-
tion of serum oxidative stress and positively correlated with
changes in serum epicatechin concentration. The authors went
onto postulate a potential beneficial effect of polyphenols with re-
gard to atherothrombosis and cardiovascular disease. In our case,
the samples have even higher polyphenol concentrations and less
fat and glucose.
Much attention has been devoted to the effect of these antiox-
idants on lipoprotein peroxidation induced by copper ex vivo (Gaut
& Heinecke, 2001). Our studies reveal that the polyphenol-rich co-
coa extracts inhibit the lipid peroxidation of plasmatic lipoproteins
(Table 5). The mechanisms by which Cu2+ ions initiate and propa-
gate the oxidation of LDL involve both a-tocopheroxyl (a-Toc-O)
and hydroxyl (OH) radicals, both of which may be responsible
for the initiation of polyunsaturated fatty acid oxidation (Horsley
et al., 2007). At 100 lg/mL, the polyphenol-rich cocoa extracts
exhibited no copper chelating activity, nor did they show any
apparent hydroxyl radical scavenging activity. The antioxidant
property of these extracts in copper-induced plasma oxidation
may thus be explained by the chain-breaking activity of polyphe-
nols, which act as H-donors to the peroxy radical and provoke
the termination of radical chain reactions.
The results of studies on the bioavailability of cocoa polyphe-
nols in vivo have been contradictory at best. Still, Rios, Bennet,
Lazarus, Rémésy, and Scalbert (2002) reported on the stability of
procyanidins during gastric transit in humans while Holt et al.(2002) detected procyanidin dimer B2 (41 nmol/L) in human plas-
ma 2 h after the consumption of an enriched sample of cocoa
(256 mg). Notwithstanding, other derivatives are detected in high-
er values (epicatechin 5.92 lg/mL and catechin 0.16 lg/mL). These
values are within the range of activity showed in vitro by these
compounds (Hatano et al., 2002), which are in concordance with
the values obtained in our experiments.
The total polyphenols and flavanols quantified in the cocoa
powder rich in polyphenols (sample A) were much higher than
the standard cocoa powder (Table 1), but similar to those found
in another previously reported cocoa polyphenol (Cienfuegos-
Jovellanos et al., 2009). Furthermore, after the extraction process,
the cocoa extract (sample B) contained three times more epicate-
chin and five times more procyanidin B2 than its respective control
(the cocoa cake before treatment). The purification step resulted in
a concentration of epicatechin monomer of 300 mg/g. The high
amount of these flavanols of low molecular weight, especially the
monomer ()-epicatechin, is thought to be important because
an increase in plasma ()-epicatechin is accompanied by a dose-
dependent increase in plasma antioxidant capacity (Rein,
Paglieroni et al., 2000; Rein, Lotito et al., 2000; Serafini et al.,
2003), and a dose-dependent decrease in plasma lipid oxidation
(Rein, Paglieroni et al., 2000; Rein, Lotito et al., 2000). According
to the results shown in Table 2, applying a heat treatment of
121 C for 1 min did not result in any loss of total monomers and
dimers as quantified by means of HPLC-DAD. The results confirm
that the wet heat treatment produces polyphenol-rich cocoa pow-
der that meets the microbiological standards for its commercializa-
tion without altering the phenolic composition. The differences
observed in the total polyphenol and flavan-3-ol content of the
standard cocoa powder as compared to that found in the polyphe-
nol-rich cocoa products indicate the importance of the production
process in the preservation of polyphenol from the original cocoa.
In conclusion, these cocoa products may constitute an impor-
tant source of polyphenols to serve as functional ingredients for
the food and cosmetics industries if the extractive protocol is
characterized and defined in advance to obtain values of catechin,
epicatechin, and procyanidin in ranges that would allow them to
reach physiologically active values in the blood and tissue. In par-
allel, the development and validation of biological markers could
be of great interest to determine the efficacy of dietary
antioxidants.
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